Archives of Gynaecology and Women Health

Abstract

Hypertensive disorders of pregnancy HDP is the second leading cause of global maternal mortality behind maternal hemorrhage and is a significant cause of short- and long-term maternal and fetal/offspring morbidity. This study aimed to measure the ferritin level among Sudanese women with hypertensive disorders of pregnancy This was a case-control hospital-based study conducted at the laboratory of the Omdurman maternity hospital – in Khartoum, Sudan, during the period of January 2023 to March 2023. It included All patients attending Omdurman maternity hospital that diagnosed with hypertensive disorders of pregnancy, and apparently healthy women were included as a control group. ELISA was used for ferritin level measurement. The mean of ferritin levels in the cases was 102.5±19.4, and in the control group it was 114.1±11.7. when compared the ferritin means between the case and control groups, there were insignificant differences with p-value=0.613. In addition to that, ferritin levels had insignificant differences with the history of hypertension, types of hypertensive pregnancy, and negative correlation with age (p. v > 0.05). Among Sudanese women with hypertensive pregnancy, ferritin levels had insignificant differences when compared betweenthe case and control groups; in addition, they had insignificant differences with the history of hypertension and types of hypertensive pregnancy and had a negative correlation with age.

Introduction

Hypertensive disorders of pregnancy are a group of high blood pressure disorders, one of the three major causes of death in pregnancy that include preeclampsia and preeclampsia superimposed on the body. It consists of an apoprotein shell (mol. wt. 480000) that encloses a core of iron in the form of ferric hydroxy-phosphate, which may contain up to chronic hypertension, gestational hypertension, and chronic hypertension. About 10% of pregnancies globally are complicated by hypertensive diseases. [1-2] Ferritin provides the primary form of iron storage in the 4500 atoms of iron. Ferritin is a soluble protein but is degraded to an insoluble derivative, hemosiderin, which accumulates in lysosomes and is the ‘stainable iron referred to by pathologistsand hematologists. Normally much of the storage iron in the body (approx. 1 g in men and less in women) is in ferritin, but with increasing iron overload, the proportion presentas hemosiderin increases. The ferritin in human tissues contains two types of subunits: H and L. H subunits have a molecular weight of 21,000 and are found in the more acidic isoferritins in the heart, red blood cells, lymphocytes, monocytes, HeLa cells, and other tissues. L subunits have a molecular weight of 19000 and predominate in the more basic isofenitins of the liver, spleen, and placenta. Variation in the ratio of H to L subunits explains the charge heterogeneity of ferritin, which is most readily demonstrated by isoelectric focusing. The isoelectric point of ferritin is not significantly affected by its iron content, which varies from tissue to tissue and with the iron content of tissue. [3]

Material and Method

This was a case-control hospital-based study conducted at the laboratory of the Omdurman maternity hospital – in Khartoum, Sudan, during the period of January 2023 to March 2023. It included All patients attending Omdurman maternity hospital that diagnosed with hypertensive disorders of preg- nancy, and apparently healthy women were included as a control group. participants under folic acid or iron therapy and those with a previous history of hypertensive disorders of pregnancy were excluded. The study was approved by the ethical committee of a national university and the faculty of medical laboratory, and the participants were fully informed about the advantages and disadvantages before participatingin the research (verbal informed consent). From each participant, 3 ml of venous blood was collected in sterile plain containers. ELIZA was used for ferritin level measurement. SPSS version 23 statistical software (SPSS Inc., USA) was used for statistical analysis.

Results

A total of sixty participants were enrolled, thirty as a case group and thirty as a control group. the mean ages in the case group were 30.8±6.9, and in the control group were 28.9±5.5. In the case group, 20% had a history of abortion one time, 26.7% had pregnancy for the first time, 50% were diagnosed with preeclampsia, and 50% were diagnosed with eclampsia. In addition, 63% had a family history of hypertension (Table 1) (Figures 1-4).

Table 1: Descriptive Statistics

Figure 1: Distribution of the number of pregnancies

Figure 2: Distribution of abortion numbers

Figure 3: Distribution of Diagnosis

Figure 4: Distribution of hypertension family history

Hematological Result:

In the present study, the results showed that the mean of ferritin levels in the cases was 102.5±19.4, and in the control group, it was 114.1±11.7. when comparing the ferritin means between the case and control groups, there were insignificant differences with p.v. = 0.613 (figure 5) (table 2). in addition to that, ferritin level had insignificant differences with the history of hypertension, types of hypertensive pregnancy, and negative correlation with age (p. v > 0.05) (Table 3-5).

Figure 5: Mean of ferritin in case and control

Table 2: Comparison of ferritin levels between case and control

Table 3: Comparison of ferritin level according to the history of hypertension

Table 4: Comparison of ferritin, protein C, protein S, and folate according to diagnosis

Table 5: Correlations of age with ferritin

Discussion

The hypertensive syndromes of pregnancy are the leading cause of maternal and fetal morbidity and mortality in the developed world, occurring in around 8% of pregnancies. Several studies have suggested a possible role for the nitric oxide synthase gene and the HLA system in the genesis of the disease, which would fit within a wider picture of maternal immune responses to the trophoblast that lead to defective placentation, activation of the inflammatory cascade, and endothelial dysfunction. [4] This was a case-control hospital-based study conducted at the laboratory of the Omdurman maternity hospital - Khar- toum, Sudan, during the period of January 2023 to March 2023, and it aimed to measure the ferritin Level among Sudanese Women with Hypertensive Disorders of pregnancy. the results showed that in the case group, the mean age was 30.8±6.9, 20% had a history of abortion for one time, 26.7% had pregnancy for the first time, 50% were diagnosed as preeclampsia, and 50% were diagnosed as eclampsia. in addition, 63% had a family history of hypertension. This finding agreed with Zhang et al., who reported, The incidence of eclampsia, severe preeclampsia, and superimposed preeclampsia remained unchanged during the 10 years. Women with preeclampsia and eclampsia had a 3- to 25-fold increased risk of severe complications. African American women not only had a higher incidence of hypertensive disorders in pregnancybut also tended to have a greater risk for more severe complications. Preeclamptic and eclamptic women younger than 20 years or older than 35 years had substantially higher morbidity. [5] However, Mohamedain et al. mentioned that in the women with preeclampsia who had a history of spontaneous abortion, There was no significant difference in age, parity, education level, employment status, blood group, body mass index, and hemoglobin level between the patient and control groups. Also revealed that previous spontaneous abortion reduced the risk of preeclampsia by 59.0%. [6] Similarly, Su et al. reported that a history of induced abortion was associated with a lower risk of preeclampsia among nulliparous women in China. Moreover, Parker et al. observed a 10% reduction in the risk of preeclampsia in women with a history of one induced abortion and a 30% reduction in women with a history of three or more induced abortions. [7-8] In the present study, the results revealed that; The mean of ferritin levels in the cases was 102.5 ± 19.4, and in the control group it was (114.1±11.7), when comparing the ferritin means between the case and control groups, there were insignificant differences with (p. v= 0.613), in addition to that, ferritin level had insignificant differences with the history of hypertension, types of hypertensive pregnancy, and negative correlation with the age (p. v. > 0.05). These results consist of the Taeubert et al. study, which reported, In nonpregnant populations, higher serum ferritin, which reflects high iron stores, is associated with an increased risk of hypertension. No consistent associations were present of maternal iron status in early pregnancy with gestational hemodynamic adaptations or the risks of gestational hypertensive disorders. Also, Shaheen et al. found that in preeclamptic women, Ferritin levels were not significantly (p=0.23) different when compared between the case and control groups. [9-10] On the contrary, Raman et al.'s study found that; Mean of ferritin levels was significantly elevated both in PIH and eclampsia as compared to controls, indicating that ferritin measurement in PIH and eclampsia would not reflect iron nutritional status. [11] In addition, Amal et al.'s results showed that patients with preeclampsia have higher levels of serum ferritin compared to control subjects. [12] also, Hubel et al. said, Total serum ferritin concentrations were approximately fivefold higher in preeclampsia than in women with healthy pregnancies, which contributed to increased cellular damage in preeclampsia. It was also hypothesized that ferritin synthesis is increased in preeclampsia. This is attributed to hepatocelluar rather than placental damage. [13] However, in another study, it was reported that increased serum iron and ferritin are rendered to decreased hepcidin levels, the peptidehormone that coordinates iron absorption and distribution, in women with preeclampsia. Although it was reported by Muhsin et al. that serum hepcidin levels were within the normal ranges in women with preeclampsia, they were yet significantly higher than in controls. [12] Finally, Goldenberg et al. concluded their study with, Plas-Plasma ferritin is considered the best measure of total body iron, with low levels diagnostic of iron deficiency. High levels have been associated with inflammation and infection. High, but not low, plasma ferritin levels, especially at 26 weeks, were strongly associated with subsequent preterm delivery and birth weight. [14]

Conclusion

Among Sudanese women with hypertensive pregnancy, ferritin levels had insignificant differences when compared between the case and control groups; in addition, they had insignificant differences with the history of hypertension and types of hypertensive pregnancy, and had a negative correlation with age.

References

1. Soriano, Joan B., Amanuel Alemu Abajobir, Kalkidan Hassen Abate, Semaw Ferede Abera, Anurag Agrawal, Muktar Beshir Ahmed, Amani Nidhal Aichour et al. "Global, regional, and na- tional deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015." The Lancet Respirato- ry Medicine 5, no. 9 (2017): 691-706.
   View at Publisher | View at Google Scholar
2. Fitzmaurice, Christina, Christine Allen, Ryan M. Barber, Lars Barregard, Zulfiqar A. Bhutta, Hermann Brenner, Daniel J. Dicker et al. "Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and dis- ability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study." JAMA oncology 3, no. 4 (2017): 524-548.
   View at Publisher | View at Google Scholar
3. Finer, Lawrence B., and Mia R. Zolna. "Declines in unintend- ed pregnancy in the United States, 2008–2011." New England journal of medicine 374, no. 9 (2016): 843-852.
   View at Publisher | View at Google Scholar
4. Barra, Sérgio, Maria do Carmo Cachulo, Rui Providência, and António Leitão-Marques. "Hypertension in pregnancy: The cur- rent state of the art." Revista Portuguesa de Cardiologia (En- glish Edition) 31, no. 6 (2012): 425-432.
   View at Publisher | View at Google Scholar
5. Zhang, Jun, Susan Meikle, and Ann Trumble. "Severe maternal morbidity associated with hypertensive disorders in pregnan- cy in the United States." Hypertension in pregnancy 22, no. 2 (2003): 203-212.
   View at Publisher | View at Google Scholar
6. Mohamedain, Ahmed, Duria A. Rayis, Nadiah AlHabardi, and Ishag Adam. "Association between previous spontaneous abortion and preeclampsia: a case–control study." BMC Preg- nancy and Childbirth 22, no. 1 (2022): 715.
   View at Publisher | View at Google Scholar
7. Parker, Samantha E., Mika Gissler, Cande V. Ananth, and Mar- tha M. Werler. "Induced abortions and the risk of preeclampsia among nulliparous women." American journal of epidemiology 182, no. 8 (2015): 663-669.
   View at Publisher | View at Google Scholar
8. Su, Yinhua, Xiaoping Xie, Yanfang Zhou, Hong Lin, Yamei Li, Na Feng, and Jiayou Luo. "Association of induced abortion with hypertensive disorders of pregnancy risk among nullipa- rous women in China: a prospective cohort study." Scientific Reports 10, no. 1 (2020): 5128.
   View at Publisher | View at Google Scholar
9. Taeubert, Minerva J., Clarissa J. Wiertsema, Marijn J. Ver- meulen, Hugo G. Quezada-Pinedo, Irwin K. Reiss, Martina U. Muckenthaler, and Romy Gaillard. "Maternal iron status in ear- ly pregnancy and blood pressure throughout pregnancy, pla- cental hemodynamics, and the risk of gestational hypertensive disorders." The Journal of nutrition 152, no. 2 (2022): 525-534.
   View at Publisher | View at Google Scholar
10. Shaheen, Ghazala, Sabahat Sajid, and Sarwat Jahan. "Evalu- ation of coagulation factors and serum ferritin in preeclamptic Pakistani women." JPMA J Pakistan Med Association 70, no. 11 (2020): 2048-50.
    View at Publisher | View at Google Scholar
11. Raman, L., A. B. Pawashe, and P. Yasodhara. "Hyperferritin- emia in pregnancy induced hypertension and eclampsia." Jour- nal of Postgraduate Medicine 38, no. 2 (1992): 65-67.
    View at Publisher | View at Google Scholar
12. ElShahat, Amal M., Zakia M. Ibrahim, Eman A. Kishk, Rabab A. Basuony, and Omima T. Taha. "Increased serum ferritin lev- els in women with preeclampsia." Journal of Clinical Obstetrics and Gynecology Research (2020): 1-6.
    View at Publisher | View at Google Scholar
13. Hubel, Carl A., Lisa M. Bodnar, Ariel Many, Gail Harger, Rober- ta B. Ness, and James M. Roberts. "Nonglycosylated ferritin predominates in the circulation of women with preeclampsia but not intrauterine growth restriction." Clinical chemistry 50, no. 5 (2004): 948-951.
    View at Publisher | View at Google Scholar
14. Goldenberg, Robert L., Tsunenobu Tamura, Mary DuBard, Kelley E. Johnston, Rachel L. Copper, and Yasmin Neggers. "Plasma ferritin and pregnancy outcome." American journal of obstetrics and gynecology 175, no. 5 (1996): 1356-1359.
    View at Publisher | View at Google Scholar